Drawing for PROVA

USPTO serial 79293649

PROVA

Reviewed by CopyMark Law Group

Reg. 6297700Status 404
Filing date
Status date
Registration date
Mar 23, 2021
Examiner
NASSERGHODSI, SAHAR
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Recorded and downloadable software for medical purposes, namely, software for use in allowing users to query an analytical system in the field of healthcare and pharmaceutical products; recorded and downloadable software applications for medical purposes, namely, intelligent personal assistant software for voice recognition and natural language processing for the purposes of monitoring and improving patient health; recorded and downloadable computer software, namely, chatbot software enabling users to use natural voice to query an analytical system through a Web page or mobile tool for generating and simulating conversations in the field of health and pharmaceutical products; recorded and downloadable software applications for medical applications, namely, software for collecting, processing, transmitting and displaying medical data collected from medical patient monitoring equipment; downloadable mobile applications for receiving, processing, transmitting data collected from patients and from patient monitoring equipment for the purpose of providing information regarding pharmaceutical products and healthcare; data collection devices, namely, electronic monitors for use in receiving, processing, transmitting and displaying medical data collected from patients and from medical patient monitoring equipmentSECTION 70 - CANCELLED
042Providing medical and scientific research information in the field of pharmaceutical and clinical trials and studies; providing scientific information in the field of pharmaceutical and clinical trials and studies via the Internet, electronic media and data banks; provision of scientific information in the field of pharmaceutical and clinical trials and studies concerning clinical study results and clinical study data by means of interactive web sites; providing scientific information in the field of pharmaceutical and clinical trials and studies via Internet pages, electronic tools and data banks; provision of scientific information in the field of pharmaceutical and clinical trials and studies concerning clinical studies and results thereof from a data bank which can be consulted online; providing on-line non-downloadable software applications for providing medical and scientific research information in the field of pharmaceutical and clinical trials and studiesSECTION 70 - CANCELLED
044Providing medical and health information; providing medical information via Internet pages, electronic tools and databasesSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 6, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 11, 2021GPNXNOTIFICATION PROCESSED BY IB
Jan 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 23, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2020ALIEASSIGNED TO LIE
Nov 30, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2020XAECEXAMINER'S AMENDMENT ENTERED
Nov 30, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 30, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Nov 30, 2020CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 24, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2020RFNTREFUSAL PROCESSED BY IB
Oct 30, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2020RFRRREFUSAL PROCESSED BY MPU
Oct 6, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2020DOCKASSIGNED TO EXAMINER
Oct 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Sep 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance